When and Where
Print your Invitation
Travelling / Transportation Info
Mark Your Calendar
Speakers Registration (Abstracts Submission)
Submit a Workshop
Become a Sponsor / Partner
Join MEMBS Committee
This page will be available by 1 August 2017
This page will be available by 1st October 2017
Prof. Fahd Al-Mulla
Fahd Al-Mulla is the Director of the Research Core Facility (RCF) in Kuwait University Health Sciences Center. He is a Fellow of the Royal College of Physicians of Edinburgh. After he gained his M.B.,Ch.B., Ph.D degrees from Glasgow U.K and postdoctoral training, he realized the lack of infrastructure pertaining to the fields of Genomics, Proteomics and cellular Biology in his home University. To alleviate the suffering of his fellow researchers and future recruits, he established a state-of-the-art facility specialized in molecular technology. RCF can be visited by clicking on this link (http://www.hsc.edu.kw/vpo/rcf). He heads a Molecular Pathology Unit, which aims at delivering state-of-the-art diagnostic, targeted/personalized therapy for cancer patients and molecular genetics (http://www.al-mulla.org).
Currently, as Head of Molecular Pathology, he is focused on identification of novel metastasis suppressor genes in colorectal cancer and spearheads a collaborative effort to promote public awareness as regards to the importance of scientific research outputs in resolving society’s problems and in expediting the scientific development process in the Arab world especially in the field of the Arab Genome, the Human Variome Project and their relevance and application to clinical pathology. To that end, Dr. Al-Mulla aims at narrowing the gap in technological advancement and health inequalities between the West and the Middle East.
Dr. Al-Mulla’s identified and characterized two metastasis suppressor genes. His work now focuses on identifying mechanisms of RAF Kinase Inhibitory Protein (RKIP) metastasis suppression.